RECORDATI SECURES GERMAN OK FOR ZANITEK

Italy-based pharmaceutical firm Recordati has received approval for its antihypertensive Zanitek, a fixed combination of lercanidipine and enalapril, from the German medicines agency, BfArM.

Pharmaceutical Business Review Online (http://www.pharmaceutical-business-review.com/article_news.asp?guid=1F41018E-139F-4E08-9FA3-78312520D581)